3 active not recruiting. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 3 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow Disease Progression: new trials by email Literature Review of Disease Progression trials Research Report on Disease Progression
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP) FNP-223, Placebo - Progressive Supranuclear Palsy | Phase 2 | Active not recruiting | Ferrer Internacional S.A. | 241 | 2024-07-23 | 2025-10-15 |
| Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer Cetuximab, Encorafenib, Nivolumab - BRAF NP_004324.2:p.V600E, Metastatic Colon Adenocarcinoma | Phase 1 / Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 38 | 2019-06-14 | 2026-06-11 |
| Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission DC vaccine - Acute Myeloid Leukemia | Phase 2 | Active not recruiting | Zwi Berneman | 130 | 2012-10-01 | 2024-03-12 |
Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Leukemia, Myeloid, Acute (1) · Pathologic Complete Response (1) · Rectal Neoplasms (1) · Supranuclear Palsy, Progressive (1)
Disease Attributes (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Neoplasms (2) · Basal Ganglia Diseases (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Colonic Diseases (1) · Cranial Nerve Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Eye Diseases (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1)
Cetuximab (1) · Nivolumab (1) · encorafenib (1) · lentiviral minigene vaccine of COVID-19 coronavirus (1)
Ferrer Internacional S.A. (1) · M.D. Anderson Cancer Center (1) · Zwi Berneman (1)
United States (2) · Belgium (1) · France (1) · Germany (1) · Hungary (1) · Italy (1) · Poland (1) · Portugal (1) · Spain (1) · United Kingdom (1)
Ann Van de Velde, MD, PhD (1) · Evelien LJ Smits, MSc, PhD (1) · Van K Morris (1) · Zwi Berneman, MD, PhD (1)